Enara Health

Keto & PCOS: A Winning Combo? 🥑✨ A new study dives into the ketogenic diet (KD) for PCOS management, and here are the Top 3 Takeaways: 1️⃣ The keto group saw more weight and BMI reduction than traditional treatments like lifestyle changes and oral contraceptives. 2️⃣ Both approaches lowered key PCOS hormones like LH and testosterone, but KD took the lead for stronger improvements. 3️⃣ Keto significantly cut insulin resistance, blood sugar, and triglycerides—great news for managing PCOS-related metabolic issues. Something to Think About: While keto worked wonders short-term, the traditional method boosted good cholesterol (HDL), which keto didn’t. Is keto the way to go, or should we focus on something more sustainable? Let’s discuss! 👇 🔗 Read more: https://lnkd.in/gpDm8qg2 #PCOS #Keto #Hormones #WeightLoss #MetabolicHealth #Health #Healthcare #Diet #Nutrition #Cholesterol #Testosterone #Metabolic #Metabolism #Glucose #Lipid #Obgyn #Lifestyle #Science #PublicHealth #Treatment #Overweight #Obese #Obesity #Weight #BMI #Insulin #InsulinResistance #Sugar American College of Obstetricians and Gynecologists (ACOG)

New research shows GLP-1 medications aren’t just for weight loss—they also help lower #cholesterol! 🩺✨ Here’s what stood out: 1️⃣ GLP-1 receptor agonists (like Wegovy) lowered "bad" cholesterol (LDL-C) by about 3 mg/dL and total cholesterol by ~7 mg/dL. 2️⃣ The cholesterol drop happened independently of weight reduction—there’s something more going on here! 3️⃣ Sadly, there was no major effect on triglycerides, VLDL, or HDL (“good” cholesterol). While the effect is modest, every bit counts for heart health. Combined with other treatments, GLP-1s could be part of the puzzle! 🔗 Read more: https://lnkd.in/gBER6JQt #Heart #Health #Healthcare #Science #PublicHealth #Lipid #GLP1 #GLP1RA #Cholesterol #LDL #HDL #Triglyceride #Weight #WeightLoss #Wegovy #Ozempic #Semaglutide #Liraglutide #Dulaglutide #Cardiometabolic #Research #RCT #Obesity #Statin American Heart Association American College of Cardiology Obesity Medicine Association National Lipid Association Novo Nordisk

A new research suggests therapy + meds can stop Binge Eating! 🍽️✨ 1️⃣ Best Results with the Combo: CBT + lisdexamfetamine (LDX) led to the highest binge-eating remission rate at 70%, compared to CBT or LDX alone. 2️⃣ Weight Loss Gains: CBT + LDX helped participants achieve significant weight loss, with over 5% body weight reduction. 3️⃣ Mental Health Boost: This combo was also most effective in reducing psychological challenges related to BED. Tackling both behavior and medication is important for managing BED and weight loss. That’s why, at Enara Health, our team includes not just #medical providers, #nutrition specialists, and #exercise experts, but also a #psychologist who works alongside you to build sustainable habits. Together, we create a comprehensive plan for long-term success. 💙 🔗 Read more: https://lnkd.in/gFaypWEk #BingeEatingDisorder #Awareness #Counseling #BED #BingeEating #Therapy #MentalHealthMatters #WeightManagement #Health #Habits #MentalHealth #CBT #Cognitive #Behavior #Medication #Lisdexamfetamine #Psychology #Psychiatry #BehavioralHealth #RCT #Research #Medical #Healthcare #Weight #WeightLoss #PublicHealth American Psychological Association Obesity Medicine Association

Does fat loss really improve insulin resistance? A new study says yes! 👏⬇️ 🔥 Fat loss drives metabolic health: Losing at least 5% body fat led to big improvements in insulin resistance, liver fat, and visceral fat. 💡 Small changes matter: A reduction of just 3.2% in body fat had noticeable benefits for insulin resistance. 🏋️ Muscle mass is key: Effective strategies focus on reducing fat while keeping muscle intact. This highlights the power of smart, science-backed weight loss for better metabolic health. Losing fat while preserving muscle isn’t just effective—it’s essential for lasting results. At Enara Health, we’re all about creating sustainable habits that transform lives. Together, we target fat loss, build healthy routines, and achieve long-term success. 🌟 🔗 Read more: https://lnkd.in/gfQwwfBR #WeightLoss #MetabolicHealth #FatLoss #InsulinResistance #HealthyLiving #Insulin #Obesity #Overweight #Weight #Metabolism #Health #Healthcare #Science #Liver #Disease #PublicHealth #Lifestyle #Nutrition #Diet #Exercise #Muscle #Activity #Fat #Habits #Changes

🎥 Thrilled to officially launch our partnership with Good Heart Medical Group, Inc. in Santa Ana & Garden Grove, CA! Together, we’re addressing #obesity and #heart health—two major drivers of chronic disease—with a comprehensive, physician-led program. At Enara Health, we go beyond weight loss, helping patients build healthier habits through personalized nutrition, activity, and behavioral support. By combining our expertise, we’re preventing complications like #diabetes and #hypertension and empowering patients to achieve long-term health. This is the future of care—specialists and innovation transforming outcomes. 💙 #Healthcare #B2B #B2C #Health #PublicHealth #Cardiology #Obesity #Weight #Lifestyle #Habits #Partnership #Science #Program #WeightLoss #California #SantaAna #GardenGrove #Insurance #Ozempic #Wegovy #Mounjaro #Zepbound #Diet #Nutrition #Food #Activity #Exercise #Behavior #Medication #Medicine #Prevention #Future #Data

Excited to partner with Good Heart Medical Group, Inc., leaders in cardiology serving Santa Ana & Garden Grove, CA! Together, we’re bringing Enara Health’s innovative, data-driven obesity care to the heart of Orange County. 🧡 By combining cardiology expertise with personalized obesity management, we’re tackling the vital connection between heart health and weight—empowering patients to live healthier, longer lives. 🌟 #EnaraHealth #GoodHeartMedicalGroup #ObesityCare #HealthRevolution #Healthcare #B2B #B2C #Health #PublicHealth #Cardiology #Obesity #Weight #Lifestyle #Habits #Partnership #Science #Heart #Program #WeightLoss #California #SantaAna #GardenGrove #Insurance #Ozempic #Wegovy #Mounjaro #Zepbound #Personalized #Diet #Nutrition #Food #Activity #Exercise #Behavior #Medication #Medicine #Prevention

Do GLP-1 RAs impact drinking habits? A new study weighs in! 🍹 📉 Nearly half of participants who drank alcohol reduced their intake after starting anti-obesity medications (AOMs). 🍻 Drugs like semaglutide may reduce the "reward" from alcohol, similar to how they curb food cravings. 🚶 Behavior matters! People in weight management programs may naturally cut back on alcohol due to calorie awareness and lifestyle changes. Cutting back on alcohol is a win for overall health, and these findings highlight the potential of GLP-1s to support that journey! This aligns with the bigger picture: lasting change comes from tools that promote healthier habits, whether through medication or mindful lifestyle shifts. 🍃 🔗 Read more on study by Lisa Matero, PhD, ABPP, Hsueh-Han Yeh & Lisiyu Ma: https://lnkd.in/gDbhYqc4 #WeightLoss #HealthyHabits #Habits #Health #Healthcare #Science #Research #Study #Medication #Alcohol #Drinking #Dependence #AlcoholConsumption #AntiObesityMedications #GLP1 #Wegovy #Ozempic #Weight #Behavior #Food #Nutrition #Lifestyle #Exercise #Diet #Semaglutide Henry Ford Health #Michigan #NewYork #Florida #MetabolicDisease #Cardiovascular #Outcomes JAMA Network Open

Zepbound Beats Wegovy in Weight Loss! 💊📉 Here are top 3 takeaways: 1️⃣ Zepbound users lost 20.2% of their body weight on average (47% more than Wegovy users). That’s a whopping 50 lbs compared to Wegovy’s 33 lbs! 2️⃣ Dual-Action Power! Zepbound combines GIP and GLP-1 hormone effects, making it unique in tackling obesity. 3️⃣ Over 30% of Zepbound users lost at least 25% of their body weight! Zepbound’s results are amazing, but let’s not overlook the importance of building a supportive environment that encourages consistent healthy choices. 🍎 🔗 Read more: https://lnkd.in/gz6HE3Ey #WeightLoss #Obesity #Zepbound #Wegovy #HealthTech #Medication #Medicine #Health #Healthcare #Publichealth #Weight #Zepbound #Wegovy Eli Lilly and Company Novo Nordisk #Semaglutide #Tirzepatide #GLP1 #Lifestyle #Consistency #Habits #Behavior #Support

New Study Uncovers Hidden Breast Cancer Risks in 'Normal Weight Obesity'! Here's what you need to know: 🤔 Women with normal BMI but high body fat (NWO) face a 19% higher risk of postmenopausal breast cancer. 🚩 Higher inflammation markers in NWO women might link excess fat to increased cancer risk. 🧬 A family history or genetic predisposition increases the risk further. This goes to show that health isn’t just about the number on the scale. A personalized approach that looks beyond BMI can help identify hidden risks and provide better pathways for prevention and overall wellness. 🧘♀️ 🔗 Read more: https://lnkd.in/gZcBgQnu #Obesity #Weight #BMI #Risk #BreastCancer #Cancer #PostMenopause #Inflammation #Research #Study #Menopause #WomensHealth #Health #Healthcare #PublicHealth #Science #Genetics #Gene #BioMarker #Analysis #Prevention #Wellness #Lifestyle #Fat

🧠 New research reveals how cardiovascular risk and obesity impact brain health! Here's what we learned: 1. Males show more brain volume loss between ages 55-64, while females experience it a decade later. 🧑🦱 2. High cardiovascular risk and obesity were major factors in this brain decline. ⚠️ 3. Whether or not you carry the Alzheimer’s risk gene (APOE ε4), cardiovascular risk and obesity still lead to a reduction in brain volume. 🧬 It’s never too late to take control of your health. Start with small changes and focus on being consistent. Over time, these small steps can add up and make a significant impact on your overall health, not just your brain health. 💪 🔗Read more: https://lnkd.in/g3-bGNGu #Brain #BrainHealth #Health #Healthcare #PublicHealth #Obesity #CardiovascularRisk #HeartHealth #Cardiology #Weight #WeightLoss #Alzheimers #Neurodegeneration #Research #Study American Neurological Association Obesity Medicine Association American Heart Association American College of Cardiology